Press Releases Prenetics Global Limited

Equities

PRE

KYG722451229

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-05 pm EDT			5-day change	1st Jan Change
6.1 ^USD	+0.33%		+5.90%	+3.21%

May. 21	Prenetics Global Limited Announces Committee Resignations	CI
Apr. 01	Prenetics Global Limited Reports Impairment Loss of Goodwill for the Fourth Quarter Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results	Apr. 01	AQ
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station	Feb. 09	AQ
PRENETICS GLOBAL : REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT - Form 6-K	Nov. 30	PU
Prenetics Announces Third Quarter 2023 Financial Results	Nov. 20	AQ
Prenetics Global Limited Announces Reverse Stock Split	Nov. 01	GL
Prenetics Announces Second Quarter 2023 Financial Results	23-09-15	GL
Prenetics Global signs "transformational" $200mln deal to create cancer screening JV	23-06-30	AQ
Prenetics Global : NASDAQ Notification Regarding Minimum Bid Price Deficiency - Form 6-K	23-06-30	PU
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening	23-06-25	AQ
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening	23-06-25	GL
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening	23-06-25	AQ
Prenetics Global : Investor Presentation (26 June 2023)	23-06-25	PU
Prenetics Announces First Quarter 2023 Financial Results	23-06-05	GL
Prenetics Global : UPDATE - Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results	23-05-01	PU
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology	23-03-14	AQ
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results	23-03-14	GL
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology	23-03-04	AQ
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology	23-03-02	GL
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology	23-03-02	AQ
Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	23-02-02	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Prenetics Global Limited

Equities

PRE

KYG722451229

Press Releases

Filters